BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1312909)

  • 1. Phase II study of ACNU as second-line treatment in small-cell lung cancer. EORTC Lung Cancer Cooperative Group.
    Planting AS; Splinter TA; Ardizzoni A; Estapé J; Giaccone G; Kirkpatrick A; Dalesio O; McVie JG
    Cancer Chemother Pharmacol; 1992; 29(5):409-11. PubMed ID: 1312909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II study of ACNU in non-small-cell lung cancer: EORTC study 08872.
    Planting AS; Ardizzoni A; Estapé J; Giaccone G; Scagliotti G; Splinter TA; Kirkpatrick A; Dalesio O; McVie JG
    Cancer Chemother Pharmacol; 1991; 28(2):145-6. PubMed ID: 1647894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II trial of nimustine (ACNU; 3-[4-amino-2-methyl-5-pyrimidinyl) methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride) in patients with small cell carcinoma of the lung after failure on combination chemotherapy.
    Joss RA; Siegenthaler P; Ludwig C; Alberto P; Castiglione MM; Cavalli F
    Invest New Drugs; 1986; 4(2):175-9. PubMed ID: 3015827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II study of ACNU as first-line treatment in advanced colorectal cancer.
    Planting A; Hoff A; van der Burg M; Verweij J; Stoter G
    Ann Oncol; 1991; 2(10):767-8. PubMed ID: 1801885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of malignant glioma with high dose intra-arterial ACNU and autologous bone marrow transplantation--case report.
    Fujiwara T; Yoshioka J; Ohmoto T
    Neurol Med Chir (Tokyo); 1991 Oct; 31(10):654-7. PubMed ID: 1725815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II study of nimustine hydrochloride (ACNU) plus paclitaxel for refractory small cell lung cancer.
    Isobe K; Kobayashi K; Kosaihira S; Kurimoto F; Sakai H; Uchida Y; Nagai Y; Yamaguchi T; Miyanaga A; Ando M; Mori G; Hino M; Gemma A
    Lung Cancer; 2009 Dec; 66(3):350-4. PubMed ID: 19342118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Phase II study of the water-soluble nitrosourea compound ACNU in advanced colorectal carcinomas].
    Fiebig HH; Wellens W; Peukert M; Henss H; Arnold H; Westerhausen M; Löhr GW
    Onkologie; 1984 Dec; 7(6):370-7. PubMed ID: 6396565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A randomized phase II study of (2''R)-4'-0-tetrahydropyranyladriamycin and adriamycin in combination with vincristine and ACNU in small cell lung cancer--THP-ADM, VCR, ACNU vs ADM, VCR, ACNU].
    Hino M; Kobayashi K; Kurane S; Nukariya N; Yamano Y; Hasegawa K; Tsuboi E; Niitani H
    Gan To Kagaku Ryoho; 1989 Sep; 16(9):3143-8. PubMed ID: 2551250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental and clinical effect of ACNU in Japan with emphasis on small-cell carcinoma of the lung.
    Saijo N; Niitani H
    Cancer Chemother Pharmacol; 1980; 4(3):165-71. PubMed ID: 6249513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II study of nimustine in metastatic soft tissue sarcoma. European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.
    Wagener DJ; Somers R; Santoro A; Verweij J; Woll PJ; Blackledge G; Schütte HJ; Lentz MA; van Glabbeke M
    Eur J Cancer; 1991; 27(12):1604-5. PubMed ID: 1782068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Randomized comparative study of CE (CDDP plus etoposide) and CE-AVN (ACNU, VCR plus procarbazine) as combined anticancer chemotherapy in small cell cancer of the lung].
    Kinoshita S; Bandou H; Yamashita T; Fukuta K; Yamasaki K; Matsuura A; Shimizu E; Ogura T; Doi H; Nakamura T
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 1):643-8. PubMed ID: 2833178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of high-dose chemotherapy with syngeneic bone marrow transplantation in experimental brain tumor in rats.
    Soma M; Shoin K; Yamashita J
    Cancer; 1993 Jan; 71(2):364-9. PubMed ID: 8422630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrathecal chemotherapy with ACNU in a meningeal gliomatosis rat model.
    Yoshida TK; Shimizu K; Koulousakis A; Sturm V
    J Neurosurg; 1992 Nov; 77(5):778-82. PubMed ID: 1403122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intensive 1-(4-amino-2-methyl-5-pyrimidinyl) methyl-3-(2-chloroethyl)-3- nitrosourea hydrochloride (ACNU) and cryopreserved autologous bone marrow transplantation].
    Sampi K; Makishima M; Kuga T; Yanagawa S; Hattori M
    Gan To Kagaku Ryoho; 1993 Oct; 20(13):1989-93. PubMed ID: 8215473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potentiation of therapeutic effects of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride by 6-thioguanine in mouse tumor systems: comparison with other antimetabolites.
    Fujimoto S; Ogawa M; Hoshino A
    Gan; 1980 Feb; 71(1):60-72. PubMed ID: 6929770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ventriculolumbar perfusion of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosou rea hydrochloride.
    Kochi M; Kuratsu J; Mihara Y; Takaki S; Seto H; Uemura S; Ushio Y
    Neurosurgery; 1993 Nov; 33(5):817-23. PubMed ID: 8264878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACNU-cisplatin continuous infusion chemotherapy as salvage therapy for recurrent glioblastomas: phase II study.
    Gwak HS; Youn SM; Kwon AH; Lee SH; Kim JH; Rhee CH
    J Neurooncol; 2005 Nov; 75(2):173-80. PubMed ID: 16132508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of a combination chemotherapy "VEMA" consisting of vincristine, cyclophosphamide, methotrexate and ACNU in the treatment of small cell bronchogenic carcinoma].
    Kojima T; Ito Y; Nakanishi F; Sugihara T; Nagata K; Kamiya O; Ohara K; Hoshino A
    Gan To Kagaku Ryoho; 1983 Jun; 10(6):1491-6. PubMed ID: 6307169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventive effects of interleukin 1 beta for ACNU-induced myelosuppression in malignant brain tumors: the experimental and preliminary clinical studies.
    Tanaka S; Tabuchi S; Watanabe K; Takigawa H; Akatsuka K; Numata H; Hokama Y; Hori T
    J Neurooncol; 1992 Oct; 14(2):159-68. PubMed ID: 1331350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor activity and toxicity of ACNU, 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitroso urea hydrochloride, comparing two divided doses and a single dose.
    Fujimoto S; Wang Y; Ogawa M
    Cancer Chemother Pharmacol; 1984; 12(3):173-8. PubMed ID: 6584235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.